The wide-ranging programme of investigation involves a core of around 200 researchers and postgraduate students, researching Alzheimer's Disease.

In addition, some indications for PET are noted in the Royal College of Physicians publication, Evidence-based indications for the use of PET-CT in the United Kingdom 2016. FDG-PET for evaluation of memory loss and neurological signs and differentiation of types of dementia in selected patients. FDOPA-PET may be useful in the assessment of Parkinsons disease in specialised centres.